Literature DB >> 25662058

High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, "adiponectin paradox": the Korean Longitudinal Study on Health and Aging (KLoSHA).

Sung Hee Choi1, Eu Jeong Ku1, Eun Shil Hong2, Soo Lim1, Ki Woong Kim3, Jae Hoon Moon1, Kyoung Min Kim1, Young Joo Park4, Kyong Soo Park4, Hak Chul Jang5.   

Abstract

BACKGROUND: The relationship between adiponectin concentration and mortality is unclear. We examined whether serum adiponectin concentration is associated with all-cause and cardiovascular mortality in elderly Asians.
METHODS: We analyzed the data for community-dwelling adults ≥65 years of age (439 men and 561 women) who were enrolled in the Korean Longitudinal Study on Health and Aging (KLoSHA) cohort in prospective manner. The baseline serum total and high molecular weight adiponectin were measured using an enzyme-linked immunosorbent assay. Using Cox regression, we determined the associations between serum adiponectin concentration and all-cause and cardiovascular mortality after adjusting for well-known cardiovascular risk factors.
RESULTS: Over a mean follow-up time of 6.2 years, 222 individuals died, and 52 deaths (23.4%) were by cardiovascular disease. After adjusting confounding factors, elevated baseline serum adiponectin concentration was independently associated with all-cause mortality (adjusted hazard ratio [HR] 1.38; 95% confidence interval [CI] 1.17-1.64) and cardiovascular mortality (HR 1.50; 1.06-2.14). We evaluated the effect modification by baseline body mass index (BMI). High serum adiponectin and low BMI were synergistically associated with increased all-cause mortality (HR 6.25; 3.08-12.71) and cardiovascular mortality (HR 13.94; 1.82-106.58).
CONCLUSIONS: Higher serum adiponectin concentration was associated with increased all-cause and cardiovascular mortality in community-dwelling elderly Asian population. Our data supported the recent theory so called "adiponectin paradox". This relationship was strengthened when combined with low BMI. We suggest that measurement of adiponectin concentration and BMI together could be an additional predictive marker of survival among elderly adults.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; All-cause mortality; Body mass index; Cardiovascular mortality; Cohort study; Elderly

Mesh:

Substances:

Year:  2015        PMID: 25662058     DOI: 10.1016/j.ijcard.2015.01.057

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  16 in total

Review 1.  Adiponectin in Diabetic Subjects Without Any Micro- or Macrovascular Complications: A Review.

Authors:  Shivananda Nayak; Geetha Bhaktha; Stephanie Mohammed
Journal:  J Diabetes Sci Technol       Date:  2015-04-24

2.  Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity.

Authors:  Edward P Weiss; Dominic N Reeds; Uthayashanker R Ezekiel; Stewart G Albert; Dennis T Villareal
Journal:  Endocrine       Date:  2016-09-07       Impact factor: 3.633

Review 3.  Diabetes and ageing-induced vascular inflammation.

Authors:  Mariam El Assar; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  J Physiol       Date:  2015-11-02       Impact factor: 5.182

4.  Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals.

Authors:  M A Larsen; V T Isaksen; E J Paulssen; R Goll; J R Florholmen
Journal:  Endocrine       Date:  2019-10-11       Impact factor: 3.633

5.  Age-related adiposity and beta-cell function: impact on prediabetes and diabetes prevalence in middle-aged and older Han Chinese adults.

Authors:  R Qiu; B Wu; Y He; S Huang; S Wang; H Li; F Zheng
Journal:  J Endocrinol Invest       Date:  2022-09-09       Impact factor: 5.467

6.  Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study).

Authors:  Guy Witberg; Colby R Ayers; Aslan T Turer; Eli Lev; Ran Kornowski; James de Lemos; Ian J Neeland
Journal:  Am J Cardiol       Date:  2015-12-31       Impact factor: 2.778

7.  Association of Circulating Brain-Derived Neurotrophic Factor with Cognition among Adult Obese Population.

Authors:  Ravi Babu Katuri; Girwar Singh Gaur; Jaya Prakash Sahoo; Zachariah Bobby; Karthik Shanmugavel
Journal:  J Obes Metab Syndr       Date:  2021-06-30

8.  Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis.

Authors:  Jiaxiang Ye; Zhongguo Liang; Qian Liang; Jinyan Zhang; Sufei Mao; Rui Liang
Journal:  Lipids Health Dis       Date:  2015-11-26       Impact factor: 3.876

9.  Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.

Authors:  Simona Hogas; Stefana C Bilha; Dumitru Branisteanu; Mihai Hogas; Abduzhappar Gaipov; Mehmet Kanbay; Adrian Covic
Journal:  Arch Med Sci       Date:  2016-03-22       Impact factor: 3.318

10.  High Molecular Weight Adiponectin Levels are Neither Influenced by Adiponectin Polymorphisms Nor Associated with Insulin Resistance in Mixed-ancestry Hyperglycemic Subjects from South Africa.

Authors:  Annalise E Zemlin; Tandi E Matsha; Andre P Kengne; Gloudina Hon; Rajiv T Erasmus
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.